;PMID: 3579983
;source_file_942.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..44] = [t:0..44]
;1)sentence:[e:50..175] = [t:50..175]
;2)section:[e:179..200] = [t:179..200]
;3)sentence:[e:204..385] = [t:204..385]
;4)sentence:[e:386..521] = [t:386..521]
;5)sentence:[e:522..645] = [t:522..645]
;6)sentence:[e:646..799] = [t:646..799]
;7)sentence:[e:800..915] = [t:800..915]
;8)sentence:[e:916..1018] = [t:916..1018]
;9)sentence:[e:1019..1240] = [t:1019..1240]
;10)sentence:[e:1241..1348] = [t:1241..1348]
;11)sentence:[e:1349..1568] = [t:1349..1568]
;12)sentence:[e:1569..1808] = [t:1569..1808]
;13)sentence:[e:1809..2093] = [t:1809..2093]
;14)section:[e:2097..2141] = [t:2097..2141]

;section 0 Span:0..44
;Biochem Pharmacol. 1987 May 1;36(9):1447-55.
(SEC
  (FRAG (NNP:[0..7] Biochem) (NNP:[8..17] Pharmacol) (.:[17..18] .)
        (CD:[19..23] 1987) (NNP:[24..27] May) (CD:[28..34] 1;36-LRB-9)
        (-RRB-:[34..35] -RRB-) (CD:[35..40] :1447) (::[40..41] -)
        (CD:[41..43] 55) (.:[43..44] .)))

;sentence 1 Span:50..175
;NADPH- and linoleic acid hydroperoxide-induced lipid peroxidation and 
;destruction of cytochrome P-450 in hepatic microsomes.
;[50..55]:substance:"NADPH"
;[61..88]:substance:"linoleic acid hydroperoxide"
;[97..102]:substance:"lipid"
;[136..152]:cyp450:"cytochrome P-450"
(SENT
  (NP-HLN
    (NP
      (NP
        (NP
          (ADJP (NN:[50..55] NADPH) (HYPH:[55..56] -)
            (ADJP-1 (-NONE-:[56..56] *P*)))
          (NML-2 (-NONE-:[56..56] *P*)))
        (CC:[57..60] and)
        (NP
          (ADJP
            (NML
              (NML (JJ:[61..69] linoleic) (NN:[70..74] acid))
              (NN:[75..88] hydroperoxide))
            (HYPH:[88..89] -)
            (ADJP-1 (VBN:[89..96] induced)))
          (NML-2 (NN:[97..102] lipid) (NN:[103..115] peroxidation))))
      (CC:[116..119] and)
      (NP
        (NP (NN:[121..132] destruction))
        (PP (IN:[133..135] of)
          (NP (NN:[136..146] cytochrome) (NN:[147..152] P-450)))))
    (PP-LOC (IN:[153..155] in)
      (NP (JJ:[156..163] hepatic) (NNS:[164..174] microsomes)))
    (.:[174..175] .)))

;section 2 Span:179..200
;Iba MM, Mannering GJ.
(SEC
  (FRAG (NNP:[179..182] Iba) (NNP:[183..185] MM) (,:[185..186] ,)
        (NNP:[187..196] Mannering) (NNP:[197..200] GJ.)))

;sentence 3 Span:204..385
;Temporal aspects of the effects of inhibitors on hepatic cytochrome P-450 
;destruction and lipid peroxidation induced by NADPH and linoleic acid 
;hydroperoxide (LAHP) were compared.
;[239..249]:substance:"inhibitors"
;[261..277]:cyp450:"cytochrome P-450"
;[295..300]:substance:"lipid"
;[325..330]:substance:"NADPH"
;[335..363]:substance:"linoleic acid  hydroperoxide"
;[365..369]:substance:"LAHP"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[204..212] Temporal) (NNS:[213..220] aspects))
      (PP (IN:[221..223] of)
        (NP
          (NP (DT:[224..227] the) (NNS:[228..235] effects))
          (PP (IN:[236..238] of)
            (NP (NNS:[239..249] inhibitors)))
          (PP (IN:[250..252] on)
            (NP
              (NP
                (NP (JJ:[253..260] hepatic)
                  (NML (NN:[261..271] cytochrome) (NN:[272..277] P-450))
                  (NN:[279..290] destruction))
                (CC:[291..294] and)
                (NP (NN:[295..300] lipid) (NN:[301..313] peroxidation)))
              (VP (VBN:[314..321] induced)
                (NP (-NONE-:[321..321] *))
                (PP (IN:[322..324] by)
                  (NP-LGS
                    (NP (NN:[325..330] NADPH))
                    (CC:[331..334] and)
                    (NP
                      (NP
                        (NML (JJ:[335..343] linoleic) (NN:[344..348] acid))
                        (NN:[350..363] hydroperoxide))
                      (NP (-LRB-:[364..365] -LRB-) (NN:[365..369] LAHP)
                          (-RRB-:[369..370] -RRB-)))))))))))
    (VP (VBD:[371..375] were)
      (VP (VBN:[376..384] compared)
        (NP-1 (-NONE-:[384..384] *))))
    (.:[384..385] .)))

;sentence 4 Span:386..521
;In the absence of added Fe2+, NADPH-induced  lipid peroxidation in hepatic
;microsomes exhibited a slow phase followed by a  fast phase.
;[410..414]:substance:"Fe2+"
;[416..421]:substance:"NADPH"
;[431..436]:substance:"lipid"
(SENT
  (S
    (PP-LOC (IN:[386..388] In)
      (NP
        (NP (DT:[389..392] the) (NN:[393..400] absence))
        (PP (IN:[401..403] of)
          (NP (VBN:[404..409] added)
             (NN:[410..413] Fe2) (SYM:[413..414] +)))))
    (,:[414..415] ,)
    (NP-SBJ
      (NP
        (ADJP (NN:[416..421] NADPH) (HYPH:[421..422] -) (VBN:[422..429] induced))
        (NN:[431..436] lipid) (NN:[437..449] peroxidation))
      (PP-LOC (IN:[450..452] in)
        (NP (JJ:[453..460] hepatic) (NNS:[461..471] microsomes))))
    (VP (VBD:[472..481] exhibited)
      (NP
        (NP (DT:[482..483] a) (JJ:[484..488] slow) (NN:[489..494] phase))
        (VP (VBN:[495..503] followed)
          (NP (-NONE-:[503..503] *))
          (PP (IN:[504..506] by)
            (NP-LGS (DT:[507..508] a) (JJ:[510..514] fast) (NN:[515..520] phase))))))
    (.:[520..521] .)))

;sentence 5 Span:522..645
;The addition of Fe2+ eliminated the slow phase, thus demonstrating  that iron
;is a rate-limiting component in the reaction.
;[538..542]:substance:"Fe2+"
;[595..599]:substance:"iron"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[522..525] The) (NN:[526..534] addition))
      (PP (IN:[535..537] of)
        (NP (NN:[538..541] Fe2) (SYM:[541..542] +))))
    (VP (VBD:[543..553] eliminated)
      (NP (DT:[554..557] the) (JJ:[558..562] slow) (NN:[563..568] phase))
      (,:[568..569] ,)
      (S-ADV
        (ADVP (RB:[570..574] thus))
        (NP-SBJ (-NONE-:[574..574] *))
        (VP (VBG:[575..588] demonstrating)
          (SBAR (IN:[590..594] that)
            (S
              (NP-SBJ (NN:[595..599] iron))
              (VP (VBZ:[600..602] is)
                (NP-PRD
                  (NP (DT:[603..604] a)
                    (ADJP (NN:[605..609] rate) (HYPH:[609..610] -)
                          (VBG:[610..618] limiting))
                    (NN:[619..628] component))
                  (PP (IN:[629..631] in)
                    (NP (DT:[632..635] the) (NN:[636..644] reaction))))))))))
    (.:[644..645] .)))

;sentence 6 Span:646..799
;EDTA, which complexes  iron, and p-chloromercurobenzoate (pCMB), which
;inhibits NADPH-cytochrome P-450  reductase, inhibited both phases of the
;reaction.
;[646..650]:substance:"EDTA"
;[669..673]:substance:"iron"
;[679..702]:substance:"p-chloromercurobenzoate"
;[704..708]:substance:"pCMB"
;[726..759]:substance:"NADPH-cytochrome P-450  reductase"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (NN:[646..650] EDTA))
        (,:[650..651] ,)
        (SBAR
          (WHNP-2 (WDT:[652..657] which))
          (S
            (NP-SBJ-2 (-NONE-:[657..657] *T*))
            (VP (VBZ:[658..667] complexes)
              (NP (NN:[669..673] iron))))))
      (,:[673..674] ,) (CC:[675..678] and)
      (NP
        (NP
          (NP (NN:[679..702] p-chloromercurobenzoate))
          (NP (-LRB-:[703..704] -LRB-) (NN:[704..708] pCMB)
              (-RRB-:[708..709] -RRB-)))
        (,:[709..710] ,)
        (SBAR
          (WHNP-1 (WDT:[711..716] which))
          (S
            (NP-SBJ-1 (-NONE-:[716..716] *T*))
            (VP (VBZ:[717..725] inhibits)
              (NP
                (NML (NN:[726..731] NADPH) (HYPH:[731..732] -)
                  (NML (NN:[732..742] cytochrome) (NN:[743..748] P-450)))
                (NN:[750..759] reductase)))))))
    (,:[759..760] ,)
    (VP (VBD:[761..770] inhibited)
      (NP
        (NP (DT:[771..775] both) (NNS:[776..782] phases))
        (PP (IN:[783..785] of)
          (NP (DT:[786..789] the) (NN:[790..798] reaction)))))
    (.:[798..799] .)))

;sentence 7 Span:800..915
;Catalase as well as scavengers  of hydroxyl radical, inhibited NADPH-induced
;lipid peroxidation almost  completely.
;[800..808]:substance:"Catalase"
;[835..851]:substance:"hydroxyl radical"
;[863..868]:substance:"NADPH"
;[877..882]:substance:"lipid"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[800..808] Catalase))
      (CONJP (RB:[809..811] as) (RB:[812..816] well) (IN:[817..819] as))
      (NP
        (NP (NNS:[820..830] scavengers))
        (PP (IN:[832..834] of)
          (NP (NN:[835..843] hydroxyl) (NN:[844..851] radical)))))
    (,:[851..852] ,)
    (VP (VBD:[853..862] inhibited)
      (NP
        (ADJP (NN:[863..868] NADPH) (HYPH:[868..869] -) (VBN:[869..876] induced))
        (NN:[877..882] lipid) (NN:[883..895] peroxidation))
      (ADVP-EXT (RB:[896..902] almost) (RB:[904..914] completely)))
    (.:[914..915] .)))

;sentence 8 Span:916..1018
;GSH also inhibited the NADPH-dependent reaction but only when added  at the
;beginning of the reaction.
;[916..919]:substance:"GSH"
;[939..944]:substance:"NADPH"
(SENT
  (S
    (NP-SBJ-2 (NN:[916..919] GSH))
    (ADVP (RB:[920..924] also))
    (VP
      (VP (VBD:[925..934] inhibited)
        (NP (DT:[935..938] the)
          (ADJP (NN:[939..944] NADPH) (HYPH:[944..945] -)
                (JJ:[945..954] dependent))
          (NN:[955..963] reaction)))
      (CC:[964..967] but)
      (VP
        (SBAR-TMP
          (WHADVP-1 (RB:[968..972] only) (WRB:[973..977] when))
          (S
            (NP-SBJ-2 (-NONE-:[977..977] *))
            (VP (VBN:[978..983] added)
              (PP-TMP (IN:[985..987] at)
                (NP
                  (NP (DT:[988..991] the) (NN:[992..1001] beginning))
                  (PP (IN:[1002..1004] of)
                    (NP (DT:[1005..1008] the) (NN:[1009..1017] reaction)))))
              (ADVP-TMP-1 (-NONE-:[1017..1017] *T*)))))))
    (.:[1017..1018] .)))

;sentence 9 Span:1019..1240
;In contrast with NADPH-dependent lipid  peroxidation, the autocatalytic
;reaction induced by LAHP was not biphasic,  NADPH-dependent or
;iron-dependent, nor was it inhibited by hydroxyl radical  scavengers,
;catalase or GSH.
;[1036..1041]:substance:"NADPH"
;[1052..1057]:substance:"lipid"
;[1111..1115]:substance:"LAHP"
;[1135..1140]:substance:"NADPH"
;[1154..1158]:substance:"iron"
;[1194..1210]:substance:"hydroxyl radical"
;[1224..1232]:substance:"catalase"
;[1236..1239]:substance:"GSH"
(SENT
  (S
    (S
      (PP (IN:[1019..1021] In)
        (NP
          (NP (NN:[1022..1030] contrast))
          (PP (IN:[1031..1035] with)
            (NP
              (ADJP (NN:[1036..1041] NADPH) (HYPH:[1041..1042] -)
                    (JJ:[1042..1051] dependent))
              (NN:[1052..1057] lipid) (NN:[1059..1071] peroxidation)))))
      (,:[1071..1072] ,)
      (NP-SBJ-1
        (NP (DT:[1073..1076] the) (JJ:[1077..1090] autocatalytic)
            (NN:[1091..1099] reaction))
        (VP (VBN:[1100..1107] induced)
          (NP (-NONE-:[1107..1107] *))
          (PP (IN:[1108..1110] by)
            (NP-LGS (NN:[1111..1115] LAHP)))))
      (VP (VBD:[1116..1119] was) (RB:[1120..1123] not)
        (ADJP-PRD
          (ADJP (JJ:[1124..1132] biphasic))
          (,:[1132..1133] ,)
          (ADJP (NN:[1135..1140] NADPH) (HYPH:[1140..1141] -)
                (JJ:[1141..1150] dependent))
          (CC:[1151..1153] or)
          (ADJP (NN:[1154..1158] iron) (HYPH:[1158..1159] -)
                (JJ:[1159..1168] dependent)))))
    (,:[1168..1169] ,) (CC:[1170..1173] nor)
    (SINV (VBD:[1174..1177] was)
      (NP-SBJ (PRP:[1178..1180] it))
      (VP (VBN:[1181..1190] inhibited)
        (NP-1 (-NONE-:[1190..1190] *))
        (PP (IN:[1191..1193] by)
          (NP-LGS
            (NP
               (NN:[1194..1202] hydroxyl) (NN:[1203..1210] radical)
              (NNS:[1212..1222] scavengers))
            (,:[1222..1223] ,)
            (NP (NN:[1224..1232] catalase))
            (CC:[1233..1235] or)
            (NP (NN:[1236..1239] GSH))))))
    (.:[1239..1240] .)))

;sentence 10 Span:1241..1348
;A synergistic effect on lipid peroxidation was  observed when both NADPH and
;LAHP were added to microsomes.
;[1265..1270]:substance:"lipid"
;[1308..1313]:substance:"NADPH"
;[1318..1322]:substance:"LAHP"
(SENT
  (S
    (NP-SBJ-3
      (NP (DT:[1241..1242] A) (JJ:[1243..1254] synergistic)
          (NN:[1255..1261] effect))
      (PP (IN:[1262..1264] on)
        (NP (NN:[1265..1270] lipid) (NN:[1271..1283] peroxidation))))
    (VP (VBD:[1284..1287] was)
      (VP (VBN:[1289..1297] observed)
        (NP-3 (-NONE-:[1297..1297] *))
        (SBAR-TMP
          (WHADVP-2 (WRB:[1298..1302] when))
          (S
            (NP-SBJ-1 (CC:[1303..1307] both) (NN:[1308..1313] NADPH)
                      (CC:[1314..1317] and) (NN:[1318..1322] LAHP))
            (VP (VBD:[1323..1327] were)
              (VP (VBN:[1328..1333] added)
                (NP-1 (-NONE-:[1333..1333] *))
                (PP (TO:[1334..1336] to)
                  (NP (NNS:[1337..1347] microsomes)))
                (ADVP-TMP-2 (-NONE-:[1347..1347] *T*))))))))
    (.:[1347..1348] .)))

;sentence 11 Span:1349..1568
;It is concluded that  both the fast and slow phases of NADPH-dependent
;microsomal lipid peroxidation  are catalyzed enzymatically and are dependent
;upon Fe2+, whereas LAHP-dependent  lipid peroxidation is autocatalytic.
;[1404..1409]:substance:"NADPH"
;[1431..1436]:substance:"lipid"
;[1502..1506]:substance:"Fe2+"
;[1516..1520]:substance:"LAHP"
;[1532..1537]:substance:"lipid"
(SENT
  (S
    (NP-SBJ-3
      (NP (PRP:[1349..1351] It))
      (SBAR-4 (-NONE-:[1351..1351] *EXP*)))
    (VP (VBZ:[1352..1354] is)
      (VP (VBN:[1355..1364] concluded)
        (NP-3 (-NONE-:[1364..1364] *))
        (SBAR-4 (IN:[1365..1369] that)
          (S
            (NP-SBJ-2
              (NP (CC:[1371..1375] both) (DT:[1376..1379] the)
                (NML
                  (NML (JJ:[1380..1384] fast)
                    (NML-1 (-NONE-:[1384..1384] *P*)))
                  (CC:[1385..1388] and)
                  (NML (JJ:[1389..1393] slow)
                    (NML-1 (NNS:[1394..1400] phases)))))
              (PP (IN:[1401..1403] of)
                (NP
                  (ADJP (NN:[1404..1409] NADPH) (HYPH:[1409..1410] -)
                        (JJ:[1410..1419] dependent))
                  (JJ:[1420..1430] microsomal) (NN:[1431..1436] lipid)
                   (NN:[1437..1449] peroxidation))))
            (VP
              (VP (VBP:[1451..1454] are)
                (VP (VBN:[1455..1464] catalyzed)
                  (NP-2 (-NONE-:[1464..1464] *))
                  (ADVP-MNR (RB:[1465..1478] enzymatically))))
              (CC:[1479..1482] and)
              (VP (VBP:[1483..1486] are)
                (ADJP-PRD (JJ:[1487..1496] dependent)
                  (PP (IN:[1497..1501] upon)
                    (NP (NN:[1502..1505] Fe2) (SYM:[1505..1506] +)))))
              (,:[1506..1507] ,)
              (SBAR-ADV (IN:[1508..1515] whereas)
                (S
                  (NP-SBJ
                    (ADJP (NN:[1516..1520] LAHP) (HYPH:[1520..1521] -)
                          (JJ:[1521..1530] dependent))
                    (NN:[1532..1537] lipid) (NN:[1538..1550] peroxidation))
                  (VP (VBZ:[1551..1553] is)
                    (ADJP-PRD (JJ:[1554..1567] autocatalytic))))))))))
    (.:[1567..1568] .)))

;sentence 12 Span:1569..1808
;Since the fast phase of enzymatic lipid  peroxidation occurred during the
;fast phase of destruction of cytochrome P-450,  it is postulated that iron
;made available from cytochrome P-450 is sufficient to  promote optimal lipid
;peroxidation.
;[1603..1608]:substance:"lipid"
;[1672..1688]:cyp450:"cytochrome P-450"
;[1713..1717]:substance:"iron"
;[1738..1754]:cyp450:"cytochrome P-450"
;[1789..1794]:substance:"lipid"
(SENT
  (S
    (SBAR-ADV (IN:[1569..1574] Since)
      (S
        (NP-SBJ
          (NP (DT:[1575..1578] the) (JJ:[1579..1583] fast)
              (NN:[1584..1589] phase))
          (PP (IN:[1590..1592] of)
            (NP (JJ:[1593..1602] enzymatic) (NN:[1603..1608] lipid)
                (NN:[1610..1622] peroxidation))))
        (VP (VBD:[1623..1631] occurred)
          (PP-TMP (IN:[1632..1638] during)
            (NP
              (NP (DT:[1639..1642] the) (JJ:[1643..1647] fast)
                  (NN:[1648..1653] phase))
              (PP (IN:[1654..1656] of)
                (NP
                  (NP (NN:[1657..1668] destruction))
                  (PP (IN:[1669..1671] of)
                    (NP (NN:[1672..1682] cytochrome) (NN:[1683..1688] P-450))))))))))
    (,:[1688..1689] ,)
    (NP-SBJ-1
      (NP (PRP:[1691..1693] it))
      (SBAR-3 (-NONE-:[1693..1693] *EXP*)))
    (VP (VBZ:[1694..1696] is)
      (VP (VBN:[1697..1707] postulated)
        (NP-1 (-NONE-:[1707..1707] *))
        (SBAR-3 (IN:[1708..1712] that)
          (S
            (NP-SBJ
              (NP-4 (NN:[1713..1717] iron))
              (VP (VBN:[1718..1722] made)
                (S
                  (NP-SBJ-4 (-NONE-:[1722..1722] *))
                  (ADJP-PRD (JJ:[1723..1732] available)
                    (PP (IN:[1733..1737] from)
                      (NP (NN:[1738..1748] cytochrome) (NN:[1749..1754] P-450)))))))
            (VP (VBZ:[1755..1757] is)
              (ADJP-PRD (JJ:[1758..1768] sufficient)
                (S
                  (NP-SBJ (-NONE-:[1768..1768] *))
                  (VP (TO:[1769..1771] to)
                    (VP (VB:[1773..1780] promote)
                      (NP (JJ:[1781..1788] optimal) (NN:[1789..1794] lipid)
                          (NN:[1795..1807] peroxidation)))))))))))
    (.:[1807..1808] .)))

;sentence 13 Span:1809..2093
;Since catalase and hydroxyl radical  scavengers inhibited NADPH-dependent but
;not LAHP-dependent lipid peroxidation,  it is concluded that the hydroxyl
;radical derived from H2O2 is the initiating  active-oxygen species in the
;enzymatic reaction but not in the autocatalytic  reaction.
;[1815..1823]:substance:"catalase"
;[1828..1844]:substance:"hydroxyl radical"
;[1867..1872]:substance:"NADPH"
;[1891..1895]:substance:"LAHP"
;[1906..1911]:substance:"lipid"
;[1952..1968]:substance:"hydroxyl radical"
;[1982..1986]:substance:"H2O2"
;[2013..2019]:substance:"oxygen"
(SENT
  (ADJP
    (SBAR-ADV (IN:[1809..1814] Since)
      (S
        (NP-SBJ
          (NP (NN:[1815..1823] catalase))
          (CC:[1824..1827] and)
          (NP
             (NN:[1828..1836] hydroxyl) (NN:[1837..1844] radical)
            (NNS:[1846..1856] scavengers)))
        (VP (VBD:[1857..1866] inhibited)
          (NP
            (NP
              (ADJP (NN:[1867..1872] NADPH) (HYPH:[1872..1873] -)
                    (JJ:[1873..1882] dependent))
              (NML-5 (-NONE-:[1882..1882] *P*)))
            (CONJP (CC:[1883..1886] but) (RB:[1887..1890] not))
            (NP
              (ADJP (NN:[1891..1895] LAHP) (HYPH:[1895..1896] -)
                    (JJ:[1896..1905] dependent))
              (NML-5 (NN:[1906..1911] lipid) (NN:[1912..1924] peroxidation)))))))
    (,:[1924..1925] ,)
    (NP-SBJ-4
      (NP (PRP:[1927..1929] it))
      (SBAR-7 (-NONE-:[1929..1929] *EXP*)))
    (VP (VBZ:[1930..1932] is)
      (VP (VBN:[1933..1942] concluded)
        (NP-4 (-NONE-:[1942..1942] *))
        (SBAR-7 (IN:[1943..1947] that)
          (S
            (NP-SBJ
              (NP (DT:[1948..1951] the)
                 (NN:[1952..1960] hydroxyl) (NN:[1961..1968] radical))
              (VP (VBN:[1969..1976] derived)
                (NP (-NONE-:[1976..1976] *))
                (PP (IN:[1977..1981] from)
                  (NP (NN:[1982..1986] H2O2)))))
            (VP
              (VP (VBZ:[1987..1989] is)
                (NP-PRD (DT:[1990..1993] the) (VBG:[1994..2004] initiating)
                  (NML (JJ:[2006..2012] active) (HYPH:[2012..2013] -)
                       (NN:[2013..2019] oxygen))
                  (NN:[2020..2027] species))
                (PP=3 (IN:[2028..2030] in)
                  (NP (DT:[2031..2034] the) (JJ:[2035..2044] enzymatic)
                      (NN:[2045..2053] reaction))))
              (CC:[2054..2057] but)
              (VP (RB:[2058..2061] not)
                (PP=3 (IN:[2062..2064] in)
                  (NP (DT:[2065..2068] the) (JJ:[2069..2082] autocatalytic)
                      (NN:[2084..2092] reaction)))))))))
    (.:[2092..2093] .)))

;section 14 Span:2097..2141
;PMID: 3579983 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2097..2101] PMID) (::[2101..2102] :) (CD:[2103..2110] 3579983)
        (NN:[2111..2112] -LSB-) (NNP:[2112..2118] PubMed) (::[2119..2120] -)
        (NN:[2121..2128] indexed) (IN:[2129..2132] for)
        (NNP:[2133..2141] MEDLINE-RSB-)))
